Job Order#: 2105-5580
Therapeutic Area: Cardiovascular
Company: This is a biopharmaceutical company that focuses on therapies for individuals with high unmet needs.
This is a critical position within the Clinical Development group. The Director will help drive recruitment in Phase II and Phase III studies in Pulmonary Arterial Hypertension (PAH). The Director will identify, evaluate and launch clinical trial sites in Europe, beginning with the Phase II study and later for Phase III planning and strategy development.
The Director will collaborate with CRO and Clinical Operations teams to address site challenges, support recruitment efforts, and answer protocol-related questions during the clinical trial. Additionally, the Director will help educate targeted members of the medical community about the company’s PAH program.